genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2012
Atrial fibrillation
News
Phase III Results Promising for Diabetes, Gaucher, Atrial Fibrillation Drugs
News
Merck Pulls Plug on Cardiome Partnership
News
FDA Green-Lights Janssen’s Anticoagulant for Reducing Stroke/Embolism in Nonvalvular AF Patients
Drug Discovery
Japan Is First Country to Approve Daiichi Sankyo’s Direct Factor Xa Inhibitor
Drug Discovery
Xention and Grünenthal Collaborate to Develop Ion Channel Modulators for Pain Therapy
Industry News
Xention Spins Out Early Clinical-Stage OAB Program into New Firm Provesica
News
Astellas and Cardiome Halt Enrollment in Phase IIIb AF Trial Following Cardiogenic Shock
News
FDA Clears BI’s Pradaxa for Preventing Stroke in Nonvalvular AF Patients
News
FDA Committee Unanimously Supports Boehringer Ingelheim’s Stroke-Prevention Drug in Atrial Fibrillation
Drug Discovery
CHMP Doles Out Two Positive Opinions on Archimedes Pharma and Merck & Co. Drugs
1
2
3
Page 2 of 3
Scroll Up
Scroll Up
